Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study
Open Access
- 14 July 2009
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 101 (3) , 390-394
- https://doi.org/10.1038/sj.bjc.6605181
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 20 references indexed in Scilit:
- Development of a New Method for Monitoring Prostate-Specific Antigen Changes in Men with Localised Prostate Cancer: A Comparison of Observational CohortsEuropean Urology, 2010
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2005
- 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate CancerJAMA, 2005
- Early outcomes of active surveillance for localized prostate cancerBJU International, 2005
- Variations in PSA doubling time in patients with prostate cancer on “watchful waiting”: Value of short-term PSADT determinationsUrology, 2004
- Active surveillance: towards a new paradigm in the management of early prostate cancerThe Lancet Oncology, 2004
- Watchful waiting in prostate cancer: review and policy proposalsBJU International, 2003
- Prostate Testing for Cancer and Treatment (ProtecT) feasibility studyHealth Technology Assessment, 2003
- Multilevel growth curve models with covariate effects: application to recovery after strokeStatistics in Medicine, 2001
- Prostate specific antigen in a community‐based sample of men without prostate cancer: Correlations with prostate volume, age, body mass index, and symptoms of prostatismThe Prostate, 1995